Form 8-K - Current report:
SEC Accession No. 0001564590-21-026993
Filing Date
2021-05-12
Accepted
2021-05-12 16:10:29
Documents
14
Period of Report
2021-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-8k_20210512.htm   iXBRL 8-K 37771
2 EX-99.1 rna-ex991_6.htm EX-99.1 155658
3 GRAPHIC gc1whwm0cpp3000001.jpg GRAPHIC 206622
  Complete submission text file 0001564590-21-026993.txt   587730

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rna-20210512.xsd EX-101.SCH 5813
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210512_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210512_pre.xml EX-101.PRE 12112
7 EXTRACTED XBRL INSTANCE DOCUMENT rna-8k_20210512_htm.xml XML 3692
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 21915172
SIC: 2834 Pharmaceutical Preparations